Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 6/2015

01-06-2015 | Original Communication

Prevalence and timeline of nonmotor symptoms in idiopathic rapid eye movement sleep behavior disorder

Authors: Carolina Aguirre-Mardones, Alex Iranzo, Dolores Vilas, Mónica Serradell, Carles Gaig, Joan Santamaría, Eduardo Tolosa

Published in: Journal of Neurology | Issue 6/2015

Login to get access

Abstract

Parkinson disease (PD) patients may experience nonmotor symptoms (NMS) before Parkinsonism onset. Patients with idiopathic REM sleep behavior disorder (IRBD) eventually develop PD and may represent premotor PD. We aimed to evaluate the prevalence and perceived timeline of NMS in IRBD through validated scales and questionnaires used in PD research. In 44 IRBD patients and 40 matched controls, overall NMS evaluation was assessed by NMS questionnaire for Parkinson disease, olfaction by University of Pennsylvania Smell Identification Test, dysautonomia by scales for outcomes in Parkinson’s disease-autonomic, constipation by Rome III criteria, depression by Hospital Anxiety and Depression Scale, cognitive impairment by Montreal cognitive assessment (MoCA) and hypersomnia by Epworth Sleepiness Scale. Patients were asked to report the perceived time of onset of hyposmia, constipation, and depression. Hyposmia (52.3 vs. 20.0 %, p = 0.002) and constipation (56.8 vs. 20.0 %, p = 0.001) were more frequent in patients than in controls. Patients reported more memory problems and showed a trend toward lower score in MoCA. Depression and hypersomnia were not more frequent in patients. The first symptom perceived was RBD in 38.6 % patients, hyposmia in 15.9 %, constipation in 11.4 %, and depression in 6.8 %. The temporal course of the NMS studied was heterogeneous. The three most common presentations were RBD followed by hyposmia; hyposmia followed by RBD; and hyposmia followed by RBD and constipation occurring at the same time span. IRBD patients frequently exhibit NMS that occur in premotor PD, particularly hyposmia and constipation. In IRBD, the perceived timeline of NMS is highly variable. This variability may suggest that pathological changes occurring in IRBD subjects are also heterogeneous and not restricted to the structures that regulate REM sleep.
Literature
1.
Tolosa E, Wenning G, Poewe W (2006) The diagnosis of Parkinson’s disease. Lancet Neurol 5:75–86CrossRefPubMed
2.
Spillantini MG, Goedert M (2000) The alpha-synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Ann N Y Acad Sci 920:16–27CrossRefPubMed
3.
Fearnley JM, Lees AJ (1991) Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 114:2283–2301CrossRefPubMed
4.
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCentralCrossRefPubMed
5.
Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5:235–245CrossRefPubMed
6.
Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24:1641–1649CrossRefPubMed
7.
Mollenhauer B, Trautmann E, Sixel-Döring F et al (2013) Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort. Neurology 81:1226–1234CrossRefPubMed
8.
Müller B, Larsen JP, Wentzel-Larsen T, Skeie GO, Tysnes OB, Parkwest Study Group (2011) Autonomic and sensory symptoms and signs in incident, untreated Parkinson’s disease: frequent but mild. Mov Disord 26:65–72CrossRefPubMed
9.
10.
Tolosa E, Gaig C, Santamaría J, Compta Y (2009) Diagnosis and the premotor phase of Parkinson disease. Neurology 72(Suppl 2):S12–S20CrossRefPubMed
11.
Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211CrossRefPubMed
12.
Boeve BF (2010) REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci 1184:15–54PubMedCentralCrossRefPubMed
13.
Arnulf I (2012) REM sleep behaviour disorder: motor manifestations and pathophysiology. Mov Disord 27:677–689CrossRefPubMed
14.
Schenck C, Boeve B, Mahowald M (2013) Delayed emergence of a parkinsonian disorder or dementia in 81 % of older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder: a 16-year update on a previously reported series. Sleep Med 14:744–748CrossRefPubMed
15.
Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M et al (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behavior disorder: an observational cohort study. Lancet Neurol 12:443–453CrossRefPubMed
16.
Postuma RB, Gagnon JF, Montplaisir J (2013) Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years. Sleep Med 14:763–767CrossRefPubMed
17.
American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien
18.
Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P et al (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest Study. Mov Disord 21:916–923CrossRefPubMed
19.
Martinez-Martin P, Schapira AHV, Stocchi F, Sethi K, Odin P, MacPhee G et al (2007) Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623–1629CrossRefPubMed
20.
Doty RL (1995) The smell identification TestTM administration manual, 3rd edn. Sensonics Inc, Philadephia
21.
Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19:1306–1312CrossRefPubMed
22.
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Functional bowel disorders. Gastroenterology 130:1480–1491CrossRefPubMed
23.
Zigmond AS, Snaith RP (1983) The Hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed
24.
Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52:69–77CrossRefPubMed
25.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed
26.
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRefPubMed
27.
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545PubMed
28.
Chiba Y, Fujishiro H, Iseki E et al (2012) Retrospective survey of prodromal symptoms in dementia with Lewy bodies: comparison with Alzheimer’s disease. Dement Geriatr Cogn Disord 33:273–281CrossRefPubMed
29.
Fujishiro H, Iseki E, Nakamura S et al (2013) Dementia with Lewy bodies: early diagnostic challenges. Psychogeriatrics 13:128–138CrossRefPubMed
30.
31.
Donaghy PC, O’Brien JT, Thomas AJ (2014) Prodromal dementia with Lewy bodies. Psychol Med 3:1–10
32.
Kim HJ, Park SY, Cho YJ et al (2009) Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. J Neurol Sci 287:200–204CrossRefPubMed
33.
Gaenslen A, Swid I, Liepelt-Scarfone I, Godau J, Berg D (2011) The patients’ perception of prodromal symptoms before the initial diagnosis of Parkinson’s disease. Mov Disord 26:653–658PubMedCentralCrossRefPubMed
34.
35.
Erro R, Santangelo G, Picillo M et al (2013) Non-motor symptoms in early Parkinson’s disease: a 2-year follow-up study on previously untreated patients. Parkinsonism Relat Disord 19:256–259CrossRefPubMed
36.
Stiasny-Kolster K, Doerr Y et al (2005) Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128:126–137CrossRefPubMed
37.
Fantini ML, Postuma RB, Montplaisir J, Ferini-Strambi L (2006) Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder. Brain Res Bull 70:386–390CrossRefPubMed
38.
Postuma RB, Gagnon JF, Vendette M, Desjardins C, Montplaisir J (2011) Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 69:811–818CrossRefPubMed
39.
Mahlknecht P, Iranzo A, Högl B et al (2015) Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD. Neurology 2015(84):1–5
40.
Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237–1244CrossRefPubMed
41.
Ponsen MM, Stoffers D, Booji J, van Eck-Smit BLF, Ech Wolters, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Ann Neurol 56:173–181CrossRefPubMed
42.
Ross Petrovitch H, Abbot RD et al (2008) Association of olfactory dysfunction with risk for future Parkinson’s disease. Ann Neurol 63:167–173CrossRefPubMed
43.
Iranzo A, Serradell M, Vilaseca I et al (2013) Longitudinal assessment of olfactory function in idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord 19:600–604CrossRefPubMed
44.
Hoyles K, Sharama JC (2013) Olfactory loss as a supporting feature in the diagnosis of Parkinson disease: a pragmatic approach. J Neurol 260:2951–2958CrossRefPubMed
45.
Olichney JM, Murphy C, Hofsteffer CR et al (2005) Anosmia is very common in the Lewy body variant of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 76:1342–1347PubMedCentralCrossRefPubMed
46.
Westervelt HJ, Stern RA, Tremont G (2003) Odor identification deficits in diffuse Lewy body disease. Cogn Behav Neurol 16:93–99CrossRefPubMed
47.
Postuma RB, Lang A, Massicotte-Marquez J, Montplaisir J (2006) Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 66:845–851CrossRefPubMed
48.
Postuma RB, Gagnon JF, Vendette M, Montplaisir JY (2009) Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson’s disease. Brain 132:3298–3307CrossRefPubMed
49.
Postuma RB, Gagnon JF, Pelletier A, Montplaisir J (2013) Prodromal autonomic symptoms and signs in Parkinson’s disease and dementia with Lewy bodies. Mov Disord 28:597–604CrossRefPubMed
50.
Ferini-Strambi L, Oertel W, Dauvilliers Y, Postuma RB, Marelli S, Iranzo A et al (2014) Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study. J Neurol 261:1112–1118CrossRefPubMed
51.
Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD et al (2001) Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology 57:456–462CrossRefPubMed
52.
Olanow CW, Wakeman DR, Kordower JH (2014) Peripheral alpha-synuclein and Parkinson’s disease. Mov Disord 29:963–966CrossRefPubMed
53.
Gelpi E, Navarro-Otano J, Tolosa E (2014) Multiple organ involvement in alpha-synuclein pathology in Lewy body disorders. Mov Disord 29:1010–1018CrossRefPubMed
54.
Iranzo A, Gelpi E, Tolosa E (2014) Neuropathology of prodromal Lewy body disease. Mov Disord 29:410–415CrossRefPubMed
55.
Frauscher B, Nomura T, Duerr S et al (2012) Investigation of autonomic function in idiopathic REM sleep behavior disorder. J Neurol 259:1056–1061CrossRefPubMed
56.
Santamaría J, Tolosa E, Valles A (1986) Parkinson’s disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 36:1130–1133CrossRefPubMed
57.
Shiba M, Bower JH, Maraganore DM et al (2000) Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case control study. Mov Disord 15:669–677CrossRefPubMed
58.
Leentjens AFG, Van den Akker M, Metsemakers JFM, Lousberg R, Verhey FRJ (2003) Higher incidence of depression preceding the onset of Parkinson’s disease: a register study. Mov Disord 18:414–418CrossRefPubMed
59.
Ferini-Strambi L, Di Gioia MR, Castronovo V, Oldani A, Zucconi M, Cappa SF (2004) Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD). Does the idiopathic form of RBD really exist? Neurology 62:41–45CrossRefPubMed
60.
Massicotte-Marquez J, Décary A, Gagnon JF, Vendette M, Mathieu A, Postuma RB, Carrier J, Montplaisir J (2008) Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology 70:1250–1257CrossRefPubMed
61.
Aarsland D, Bronnick K, Larsen JP, Tusnes OB, Alves D, for the Norwegian Park West Study Group (2009) Cognitive impairment in incident, untreated Parkinson disease The Norwegian Park West Study. Neurology 72:1121–1126CrossRefPubMed
62.
Yarnall AJ, Breen DP, Duncan DP et al (2014) Characterizing mild cognitive impairment in incident Parkinson disease. The ICICLE study. Neurology 82:308–316CrossRefPubMed
63.
Abbott RD, Ross GW, White LR et al (2005) Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 65:1442–1446CrossRefPubMed
64.
65.
Schenck CH, Mahowald MW (2002) REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 2002(25):120–138
66.
Buskova J, Klempir J, Majerova V et al (2011) Sleep disturbances in untreated Parkinson’s disease. J Neurol 258:2254–2259CrossRefPubMed
67.
Plomhause L, Dujardin K, Duhamel A et al (2013) Rapid eye movement sleep behavior disorder in treatment-naïve Parkinson disease patients. Sleep Med 14:1035–1037CrossRefPubMed
68.
Prudon B, Duncan GW, Khoo TK, Yarnall AJ, Anderson KN (2014) Primary sleep disorder prevalence in patients with newly diagnosed Parkinson’s disease. Mov Disord 29:259–262CrossRefPubMed
69.
Iranzo A (2011) Sleep-wake changes in the premotor stage of Parkinson disease. J Neurol Sci 310:283–285CrossRefPubMed
70.
Boeve BF (2013) Idiopathic REM sleep behavior disorder in the development of Parkinson’s disease. Lancet Neurol 12:469–482CrossRefPubMed
71.
Jellinger KA (2012) Neuropathology of sporadic Parkinson’s disease: evaluation and change of concepts. Mov Disord 27:8–30CrossRefPubMed
72.
Del Tredici K, Braak H (2012) Lewy pathology and neurodegeneration in premotor Parkinson’s disease. Mov Disord 27:597–607CrossRefPubMed
Metadata
Title
Prevalence and timeline of nonmotor symptoms in idiopathic rapid eye movement sleep behavior disorder
Authors
Carolina Aguirre-Mardones
Alex Iranzo
Dolores Vilas
Mónica Serradell
Carles Gaig
Joan Santamaría
Eduardo Tolosa
Publication date
01-06-2015
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 6/2015
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7742-3

Other articles of this Issue 6/2015

Journal of Neurology 6/2015 Go to the issue

Letter to the Editors

Two cases of early dystonia of the trunk in Parkinson’s disease

Original Communication

Significance of the hot-cross bun sign on T2*-weighted MRI for the diagnosis of multiple system atrophy

Original Communication

Fat-free mass and its predictors in Huntington’s disease

Pioneers in Neurology

Ivan Petrovich Pavlov (1849–1936)

Journal club

HIV-associated neurocognitive disorders

Original Communication

Single versus multiple impulse control disorders in Parkinson’s disease: an 11C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release